Meta-analysis and trial sequential analysis of ezetimibe for coronary atherosclerotic plaque compositions

Background: Lipid aggregation, inflammatory cell infiltration, fibrous cap formation, and disruption are the major causes of atherosclerotic cardiovascular disease (ASCVD) and the pathologic features of atherosclerotic plaques. Although ezetimibe’s role in decreasing blood lipids is widely known, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Bofeng, Shen, Youlu, Li, Yuhong, Wang, Xiaoyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084938/
https://www.ncbi.nlm.nih.gov/pubmed/37050908
http://dx.doi.org/10.3389/fphar.2023.1166762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084938/
https://www.ncbi.nlm.nih.gov/pubmed/37050908
http://dx.doi.org/10.3389/fphar.2023.1166762

Ejemplares similares